Align Technology (ALGN)

Nasdaq Health Care Health Care Supplies S&P 500
$166.00
+6.63 (+4.16%)
Close of Nov 06, 2026 · end-of-day data
Source: Align Technology's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$1.08B$1.47B$1.97B$2.41B$2.47B$3.95B$3.73B$3.86B$4.00B$4.03B
Cost of revenue$264.58M$356.47M$518.62M$662.90M$708.71M$1.02B$1.10B$1.16B$1.20B$1.32B
Gross profit$815.29M$1.12B$1.45B$1.74B$1.76B$2.94B$2.63B$2.71B$2.80B$2.71B
Research & development$75.72M$97.56M$128.90M$157.36M$175.31M$250.31M$305.26M$346.83M$364.20M$369.91M
Selling, general & admin——$852.40M$1.07B$1.20B$1.71B$1.67B$1.70B$1.76B$1.76B
Operating income$248.92M$353.61M$466.56M$542.49M$387.17M$976.40M$642.60M$643.34M$607.63M$545.75M
Pre-tax income$242.57M$364.80M$466.65M$562.65M$378.95M$1.01B$599.06M$641.20M$608.96M$585.29M
Income tax$51.20M$130.16M$57.72M$112.35M-$1.40B$240.40M$237.48M$196.15M$187.60M$174.94M
Net income$189.68M$231.42M$400.24M$442.78M$1.78B$772.02M$361.57M$445.05M$421.36M$410.35M
EBITDA$272.92M$391.35M$521.29M$621.48M$480.71M$1.09B$768.39M$785.74M$752.66M$783.19M
EPS (basic)$2.38$2.89$5.00$5.57$22.55$9.78$4.62$5.82$5.63$5.66
EPS (diluted)$2.33$2.83$4.92$5.53$22.41$9.69$4.61$5.81$5.62$5.65
Diluted shares81.48M81.83M81.36M80.10M79.23M79.67M78.42M76.57M74.99M72.59M
Gross margin75.5%75.8%73.6%72.5%71.3%74.3%70.5%70.1%70.0%67.2%
Operating margin23.1%24.0%23.7%22.5%15.7%24.7%17.2%16.7%15.2%13.5%
Net margin17.6%15.7%20.4%18.4%71.8%19.5%9.7%11.5%10.5%10.2%

Balance sheet

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$389.27M$449.51M$636.90M$550.42M$960.84M$1.10B$942.05M$937.44M$1.04B$1.09B
Short-term investments$250.98M$272.03M$98.46M$318.20M$0$71.97M$57.53M$35.30M$0—
Receivables$247.41M$324.19M$439.01M$550.29M$657.70M$897.20M$859.68M$903.42M$995.68M$1.10B
Inventory$27.13M$31.69M$55.64M$112.05M$139.24M$230.23M$338.75M$296.90M$254.29M$226.34M
Total current assets$952.98M$1.16B$1.30B$1.63B$1.85B$2.49B$2.42B$2.45B$2.49B$2.62B
Goodwill$61.04M$64.61M$64.03M$63.92M$444.82M$418.55M$407.55M$419.53M$442.63M$491.83M
Total assets$1.40B$1.78B$2.05B$2.50B$4.83B$5.94B$5.95B$6.08B$6.21B$6.23B
Total current liabilities$354.33M$500.05M$692.07M$970.97M$1.33B$1.92B$1.93B$2.07B$2.04B$1.92B
Total liabilities$400.76M$629.72M$799.57M$1.15B$1.60B$2.32B$2.35B$2.45B$2.36B$2.18B
Shareholders' equity$999.31M$1.15B$1.25B$1.35B$3.23B$3.62B$3.60B$3.63B$3.85B$4.05B

Cash flow

fiscal years · USD
Fiscal yearFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$247.65M$438.54M$554.68M$747.27M$662.17M$1.17B$568.73M$785.78M$738.23M$593.22M
Capital expenditures$70.58M$195.69M$223.31M$149.71M$154.92M$401.10M$291.90M$177.72M$115.58M$102.44M
Free cash flow$177.08M$242.84M$331.37M$597.56M$507.26M$771.45M$276.83M$608.06M$622.65M$490.78M
Investing cash flow$73.03M-$251.48M$6.93M-$350.44M-$231.51M-$563.43M-$213.32M-$195.94M-$254.91M-$112.44M
Financing cash flow-$95.52M-$135.50M-$369.43M-$485.54M-$30.81M-$458.33M-$501.69M-$598.34M-$355.72M-$464.58M
Share buybacks$96.22M$103.79M$300.00M$400.00M$0$375.04M$435.04M$592.36M$352.88M$465.94M
Stock-based compensation$54.15M$58.85M$70.76M$88.18M$98.43M$114.34M$133.37M$154.03M$173.70M$185.87M
Depreciation & amortization$24.00M$37.74M$54.73M$78.99M$93.54M$108.73M$125.79M$142.40M$145.03M$237.44M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.